RICHMOND, Va.--(BUSINESS WIRE)--Oct 19, 2023--Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, today announced it has entered into a drug development collaboration with the University of Virginia (UVA) to advance novel inhaled-drug candidates ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
BRENTWOOD, Tenn. & PORT WENTWORTH, Ga.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
CHICAGO--(BUSINESS WIRE)--Oct 19, 2023--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that preliminary safety and efficacy data from its ongoing Phase 2 clinical trial, THIO-101, was accepted ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
PRINCETON, N.J.--(BUSINESS WIRE)--Oct 19, 2023--<a ...